BusinessVoyager Therapeutics Selects Lead Clinical Candidate for Huntington’s DiseaseBy Nasdaq OMXJun 1, 2017, 11:27 AM UTC
BusinessVoyager Therapeutics Selects Lead Clinical Candidate for Huntington’s DiseaseBy Nasdaq OMXJun 1, 2017, 11:27 AM UTC
BusinessVoyager Therapeutics Selects Lead Clinical Candidate for Huntington’s DiseaseBy Nasdaq OMXJun 1, 2017, 11:27 AM UTC
BusinessSelecta Biosciences Announces New Preclinical Gene Therapy Data at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)By Nasdaq OMXMay 15, 2017, 12:02 PM UTC
BusinessSelecta Biosciences Announces New Preclinical Gene Therapy Data at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)By Nasdaq OMXMay 15, 2017, 12:02 PM UTC
BusinessAbeona Therapeutics Provides Update on EB-101 Gene Therapy for Severe Form of Epidermolysis Bullosa from the Society for Investigative Dermatology ConferenceBy Nasdaq OMXMay 2, 2017, 12:05 PM UTC
BusinessSelecta Biosciences Announces Presentations at the 20th Annual Meeting of the American Society of Gene & Cell TherapyBy Nasdaq OMXMay 1, 2017, 12:00 PM UTC
BusinessFate Therapeutics to Present at the 5th Annual Cell & Gene Therapy Investor DayBy Nasdaq OMXApr 20, 2017, 12:00 PM UTC
